CODOX-M/IVAC-R versus DA-EPOCH-R in double hit/triple hit lymphoma patients aged 60 years or under. Atallah-Yunes SA, Rees MJ, Witzig TE, Habermann TM, et al. Haematologica 2024 Oct 10. doi: 10.3324/haematol.2024.286168.

Read + Share

Amedeo Smart

Independent Medical Education

Atallah-Yunes SA, Rees MJ, Witzig TE, Habermann TM, et al. CODOX-M/IVAC-R versus DA-EPOCH-R in double hit/triple hit lymphoma patients aged 60 years or under. Haematologica 2024 Oct 10. doi: 10.3324/haematol.2024.286168.
PMID: 39385736